Suven Life Sciences Ltd — Quarterly Results & Earnings

₹131.70

-2.75%

Profit Growth YoY-55.74%Latest quarter

Sales Growth YoY-64.20%Latest quarter

Sales CAGR 5Y-12.00%5 year compound

Profit CAGR 5Y-24.19%5 year compound

📋

Quarterly Performance

YoY Profit Growth-55.74%

🔴 Significant decline

YoY Sales Growth-64.20%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

-1086.16%

EPS Growth 5Y

-14.08%

Interest Coverage

Higher = safer debt servicing

-21188.00

ROE

-87.22%

ROCE

-86.96%

💡

Growth Analysis

Suven Life Sciences Ltd reported YoY profit growth of -55.74% and revenue growth of -64.20% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at -12.00% and profits at -24.19% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Suven Life Sciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Healthcare Research, Analytics & Technology Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.